JP2024535868A5 - - Google Patents
Info
- Publication number
- JP2024535868A5 JP2024535868A5 JP2024517052A JP2024517052A JP2024535868A5 JP 2024535868 A5 JP2024535868 A5 JP 2024535868A5 JP 2024517052 A JP2024517052 A JP 2024517052A JP 2024517052 A JP2024517052 A JP 2024517052A JP 2024535868 A5 JP2024535868 A5 JP 2024535868A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- nucleic acid
- recombinant nucleic
- acid molecule
- recombinant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163245661P | 2021-09-17 | 2021-09-17 | |
| US63/245,661 | 2021-09-17 | ||
| PCT/US2022/076618 WO2023044461A2 (en) | 2021-09-17 | 2022-09-16 | Switch receptors using il-9 signaling domains |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024535868A JP2024535868A (ja) | 2024-10-02 |
| JP2024535868A5 true JP2024535868A5 (cg-RX-API-DMAC7.html) | 2025-09-25 |
Family
ID=83688655
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024517052A Pending JP2024535868A (ja) | 2021-09-17 | 2022-09-16 | Il-9シグナル伝達ドメインを使用したスイッチ受容体 |
| JP2024517113A Pending JP2024535872A (ja) | 2021-09-17 | 2022-09-16 | Il-9シグナル伝達ドメインを使用したスイッチ受容体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024517113A Pending JP2024535872A (ja) | 2021-09-17 | 2022-09-16 | Il-9シグナル伝達ドメインを使用したスイッチ受容体 |
Country Status (7)
| Country | Link |
|---|---|
| US (5) | US12202884B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4402161A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2024535868A (cg-RX-API-DMAC7.html) |
| CN (2) | CN118251410A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2022347445A1 (cg-RX-API-DMAC7.html) |
| CA (2) | CA3232664A1 (cg-RX-API-DMAC7.html) |
| WO (2) | WO2023044457A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12291651B2 (en) | 2021-04-07 | 2025-05-06 | Wisconsin Alumni Research Foundation | Liquid crystal-infused slippery anti-fouling surfaces |
| CA3231615A1 (en) * | 2021-09-17 | 2023-03-23 | Mikko SIURALA | Chimeric antigen receptors comprising interleukin-9 receptor signaling domain |
| EP4402161A1 (en) | 2021-09-17 | 2024-07-24 | Parker Institute For Cancer Immunotherapy | Switch receptors using il-9 signaling domains |
| WO2024019984A1 (en) * | 2022-07-18 | 2024-01-25 | Cargo Therapeutics, Inc. | Cytokine receptor switch polypeptides and uses thereof |
| WO2025039159A1 (en) * | 2023-08-21 | 2025-02-27 | Hangzhou Hervor Therapeutics Co., Ltd | Synthetic cytokine signaling system, preparation method, and uses thereof |
| WO2025117789A1 (en) * | 2023-12-01 | 2025-06-05 | Parker Institute For Cancer Immunotherapy | Engineered immune signaling constructs |
| WO2026024685A1 (en) * | 2024-07-23 | 2026-01-29 | Feromics Inc. | Uses of immunomodulatory fusion proteins to enhance efficacy of car-expressing immune effector cells |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL104570A0 (en) | 1992-03-18 | 1993-05-13 | Yeda Res & Dev | Chimeric genes and cells transformed therewith |
| WO2010006111A2 (en) | 2008-07-10 | 2010-01-14 | Merck & Co., Inc. | Methods of using compositions comprising mir-192 and/or mir-215 for the treatment of cancer |
| MA41538A (fr) * | 2014-10-17 | 2017-12-26 | Baylor College Medicine | Cellules immunitaires bipartites et tripartites de signalisation |
| CA2974998C (en) | 2015-02-12 | 2022-04-26 | Takara Bio Inc. | Chimeric antigen receptors |
| PT3328894T (pt) | 2015-08-06 | 2019-02-13 | Agency Science Tech & Res | Anticorpos de cadeia comum gama/il2rbeta |
| GB201514875D0 (en) * | 2015-08-20 | 2015-10-07 | Autolus Ltd | Receptor |
| JP7299021B2 (ja) | 2015-09-11 | 2023-06-27 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 生体関連の直交性サイトカイン/受容体ペア |
| AU2016374497B2 (en) | 2015-12-16 | 2022-03-10 | The Walter And Eliza Hall Institute Of Medical Research | Inhibition of cytokine-induced SH2 protein in NK cells |
| CN109880803B (zh) * | 2017-12-06 | 2024-06-07 | 恺兴生命科技(上海)有限公司 | 嵌合蛋白、表达嵌合蛋白的免疫效应细胞及其应用 |
| AU2019215031C1 (en) | 2018-01-31 | 2026-02-26 | Novartis Ag | Combination therapy using a chimeric antigen receptor |
| AU2019227979B2 (en) | 2018-03-02 | 2024-09-05 | Allogene Therapeutics, Inc. | Inducible chimeric cytokine receptors |
| CN110615843B (zh) | 2018-06-20 | 2023-05-09 | 上海隆耀生物科技有限公司 | 一种包含第三信号受体的嵌合抗原受体及其应用 |
| JP2020110135A (ja) | 2019-01-09 | 2020-07-27 | エーテーハー チューリッヒEth Zurich | 汎用細胞外分子センサー |
| JP2022519704A (ja) | 2019-02-08 | 2022-03-24 | シアトル チルドレンズ ホスピタル (ディービーエイ シアトル チルドレンズ リサーチ インスティテュート) | キメラサイトカイン受容体 |
| GB201911187D0 (en) * | 2019-08-05 | 2019-09-18 | Autolus Ltd | Receptor |
| WO2021050752A1 (en) * | 2019-09-11 | 2021-03-18 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric orthogonal receptor proteins and methods of use |
| WO2021141986A1 (en) | 2020-01-07 | 2021-07-15 | St. Jude Children's Research Hospital, Inc. | Chimeric gmcsf-il18 receptor |
| US20230138428A1 (en) * | 2020-02-25 | 2023-05-04 | Quell Therapeutics Limited | Chimeric receptors for use in engineered cells |
| JP2023520572A (ja) | 2020-04-06 | 2023-05-17 | シンセカイン インコーポレイテッド | オルソゴナルな受容体を発現するようにゲノムが改変されたヒト免疫細胞 |
| EP4305054A4 (en) | 2021-03-09 | 2025-03-19 | The Trustees of The University of Pennsylvania | SELECTIVE STIMULATION OF T CELLS IN SOLID TUMORS USING ONCOLYTIC VIRAL ADMINISTRATION OF ORTHOGONAL IL-2 |
| EP4082429A1 (en) * | 2021-04-28 | 2022-11-02 | Koninklijke Philips N.V. | A shell cuff |
| US11688614B2 (en) * | 2021-04-28 | 2023-06-27 | Kla Corporation | Mitigating thermal expansion mismatch in temperature probe construction apparatus and method |
| CA3231615A1 (en) | 2021-09-17 | 2023-03-23 | Mikko SIURALA | Chimeric antigen receptors comprising interleukin-9 receptor signaling domain |
| EP4402161A1 (en) | 2021-09-17 | 2024-07-24 | Parker Institute For Cancer Immunotherapy | Switch receptors using il-9 signaling domains |
| EP4554972A1 (en) | 2022-07-11 | 2025-05-21 | The Board of Trustees of the Leland Stanford Junior University | Tunable cytokine receptor signaling domains |
-
2022
- 2022-09-16 EP EP22786722.3A patent/EP4402161A1/en active Pending
- 2022-09-16 AU AU2022347445A patent/AU2022347445A1/en active Pending
- 2022-09-16 CA CA3232664A patent/CA3232664A1/en active Pending
- 2022-09-16 JP JP2024517052A patent/JP2024535868A/ja active Pending
- 2022-09-16 EP EP22786723.1A patent/EP4402162A2/en active Pending
- 2022-09-16 CA CA3232668A patent/CA3232668A1/en active Pending
- 2022-09-16 CN CN202280074481.3A patent/CN118251410A/zh active Pending
- 2022-09-16 JP JP2024517113A patent/JP2024535872A/ja active Pending
- 2022-09-16 CN CN202280074174.5A patent/CN118234746A/zh active Pending
- 2022-09-16 US US17/946,916 patent/US12202884B2/en active Active
- 2022-09-16 WO PCT/US2022/076612 patent/WO2023044457A1/en not_active Ceased
- 2022-09-16 WO PCT/US2022/076618 patent/WO2023044461A2/en not_active Ceased
- 2022-09-16 US US17/946,894 patent/US20230110313A1/en not_active Abandoned
- 2022-09-16 AU AU2022348588A patent/AU2022348588A1/en active Pending
-
2023
- 2023-06-02 US US18/328,473 patent/US12221469B2/en active Active
-
2024
- 2024-12-09 US US18/974,281 patent/US20250179148A1/en active Pending
- 2024-12-27 US US19/003,599 patent/US20250136664A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024535872A5 (cg-RX-API-DMAC7.html) | ||
| Curtis et al. | T-cell interleukin 1 receptor cDNA expressed in Chinese hamster ovary cells regulates functional responses to interleukin 1. | |
| Pillarisetti et al. | Cloning and relative expression analysis of rat stromal cell derived factor-1 (SDF-1): SDF-1 α mRNA is selectively induced in rat model of myocardial infarction | |
| Ho et al. | A receptor for interleukin 10 is related to interferon receptors. | |
| Hilton et al. | Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. | |
| Kitamura et al. | Reconstitution of functional receptors for human granulocyte/macrophage colony-stimulating factor (GM-CSF): evidence that the protein encoded by the AIC2B cDNA is a subunit of the murine GM-CSF receptor. | |
| Rajagopalan et al. | Structural basis of chemokine receptor function—a model for binding affinity and ligand selectivity | |
| Alles et al. | Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes | |
| Horuk | The interleukin-8-receptor family: from chemokines to malaria | |
| Cosman et al. | A new cytokine receptor superfamily | |
| EP1229047B1 (en) | IL-1 Receptor fusion proteins used as antagonists and methods of making and using | |
| Liew et al. | The role of innate mediators in inflammatory response | |
| Jordana et al. | Immune-inflammatory functions of fibroblasts | |
| Cameron et al. | Cytokines, chemokines and their receptors | |
| TWI713798B (zh) | 增加介白素-2(il-2)分泌量之方法和源自該方法之蛋白類 | |
| Dinarello | Targeting interleukin 18 with interleukin 18 binding protein | |
| JP2022536347A5 (cg-RX-API-DMAC7.html) | ||
| Thelen et al. | Chemokine receptor oligomerization: functional considerations | |
| Liew | The role of innate cytokines in inflammatory response | |
| JPH08507676A (ja) | 可溶性オリゴマー蛋白質の調製法 | |
| RS51602B (sr) | April receptor (bcma) i njegova upotreba | |
| RS51157B (sr) | Baff receptor (bcma), imunoregulatorni agens | |
| JP2021527700A5 (cg-RX-API-DMAC7.html) | ||
| KR20160108291A (ko) | 수용체 결합친화성이 현격히 감소된 사이토카인을 수반하는 푸소카인 | |
| NO317735B1 (no) | Isolert DNA som koder for CD40L-mutein, fremgangsmate for fremstilling av dette, rekombinant ekspresjonsvektor, vertscelle, samt CD40L-polypeptid. |